West Nile Virus in Europe and Safety of Blood Transfusion
- PMID: 27403087
- PMCID: PMC4924479
- DOI: 10.1159/000446219
West Nile Virus in Europe and Safety of Blood Transfusion
Abstract
West Nile virus (WNV) has become an increasing issue in the transfusion setting since 2002, when it was firstly shown in the USA that it can be transmitted through blood transfusion. Since then, several precautionary measures have been introduced in Europe in order to reduce the possible risk of transmission via transfusion/solid organ transplantation. In addition, the epidemiological surveillance has been tightened and the network for communication of human WNV cases strengthened. This review will focus on WNV circulation and the safety of blood in Europe.
Keywords: NAT; Proficiency panel; Transfusion risks; Virus transmission; West Nile virus.
References
-
- Rizzoli A, Jimenez-Clavero MA, Barzon L, Cordioli P, Figuerola J, Koraka P, Martina B, Moreno A, Nowotny N, Pardigon N, Sanders N, Ulbert S, Tenorio A. The challenge of West Nile virus in Europe: knowledge gaps and research priorities. Euro Surveill. 2015;20 pii: 21135. - PubMed
-
- Bondre VP, Jadi RS, Mishra AC, Yergolkar PN, Arankalle VA. West Nile virus isolates from India: evidence for a distinct genetic lineage. J Gen Virol. 2007;88:875–884. - PubMed
-
- Blitvich BJ. Transmission dynamics and changing epidemiology of West Nile virus. Anim Health Res Rev. 2008;9:71–86. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
